|
pubmed:abstractText |
Dual antiplatelet therapy using acetylsalicylic acid (ASA, aspirin) and clopidogrel is of great importance following coronary stenting. However, the variable platelet inhibitory effectiveness compromises the antithrombotic advantages provided by dual antiplatelet therapy. The aim of this single-center prospective study was to reduce the low response incidence of dual antiplatelet therapy with ASA and clopidogrel according to a prespecified therapy algorithm.
|
|
pubmed:affiliation |
Cardiovascular Center, Ruhr University Bochum, St, Josef Hospital, Gudrunstr, 56, D-44791 Bochum, Germany. Horst.Neubauer@rub.de
|
